Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
作者信息
Goodarzi Mark O, Azziz Ricardo
出版信息
Am J Med. 2008 Aug;121(8):e9; author reply e11. doi: 10.1016/j.amjmed.2008.03.010.
PMID:18691471
Abstract
摘要
相似文献
1
Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
Am J Med. 2008 Aug;121(8):e9; author reply e11. doi: 10.1016/j.amjmed.2008.03.010.
2
Role of metformin in patients with polycystic ovary syndrome: the state of the art.
Minerva Ginecol. 2008 Feb;60(1):77-82.
3
[Metformin for the treatment of polycystic ovary syndrome].
Akush Ginekol (Sofiia). 2005;44(4):37-41.
4
Polycystic ovary syndrome.
N Engl J Med. 2005 Mar 24;352(12):1223-36. doi: 10.1056/NEJMra041536.
5
[Use of metformin in polycystic ovary syndrome].
Tidsskr Nor Laegeforen. 2009 Aug 27;129(16):1644-6. doi: 10.4045/tidsskr.08.0663.
6
Metformin therapy and diabetes in pregnancy.
Med J Aust. 2004 May 3;180(9):462-4.
7
Metformin in polycystic ovary syndrome.
N Engl J Med. 2008 Apr 24;358(17):1867; author reply 1868.
8
Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome.
Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):122-4. doi: 10.1016/j.ejogrb.2007.02.001. Epub 2007 Mar 12.
9
Cardiovascular risk in women with polycystic ovary syndrome.
Minerva Endocrinol. 2007 Dec;32(4):263-73.
10
Metformin in therapy naive patients with polycystic ovary syndrome.
Hum Reprod Update. 2008 Mar-Apr;14(2):193; author reply 193-4. doi: 10.1093/humupd/dmm049. Epub 2008 Jan 28.
Zotero 插件